Sign in
Taking people in ItalyNo phase

Testing group lessons for people with asthma to help manage their disease

Tests multidisciplinary group lessons for adults with asthma to improve disease management.

Key facts

Who runs it
Istituti Clinici Scientifici Maugeri SpA
Where
Tradate, ItalySee the site
Trial code
Registry title
Role of "Asthma School" in Disease Management
Status
Recruiting
People taking part
92 people, planned
Started
1 Apr 2019
Expected to end
15 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • multidisciplinary lessons
Record updated
24 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with asthma, diagnosed according to GINA or ATS guidelines. It studies an 'Asthma School' with multidisciplinary lessons.

Age
18 to 85 years
Sex
All sexes can join.
Disease stage
Asthma diagnosed according to GINA / ATS guidelines.

Main reasons for not taking part

  • Cognitive impairment

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Asthma diagnosis according to GINA / ATS guidelines
  • Age ≥18 years

Who cannot take part

  • •cognitive impairment

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Where in Italy

  • Istituti Clinici Maugeri PneumologiaTradate, ItalyContact: Dina ViscaTaking people

About the trial

What the trial wants to find out

According to the definition provided by the GINA guidelines, asthma is characterized by a variable and reversible limitation of expiratory airflow and by the following symptoms: wheezing, dyspnoea, thoracic constriction and/or cough. The type and the severity of airflow limitation can vary over time (1) depending on external agents, such as physical exercise, polluting agents, climate changes and viral infections. The therapy is mainly based on the use of inhaled corticosteroids and bronchodilators. Patients affected by severe asthma (~ 10% of total prevalence of asthma and at high risk of exacerbations and/or hospitalization) may not control their symptoms, even if exposed to maximal doses of inhalation therapy.The behavioural sciences can potentially help to find the psychological factors behind scarce adherence and to develop strategies with the aim of improving the interactive processes between patients, medical doctors and health care professionals

The 2 groups in the trial

  • ASG= Asthma School Group, with educational interventionTreatment being tested

    experimental "asthma school" group (ASG) will attend control visits as Control Group every three months. In addiction, ASG will attend 3 further meetings consisting in multidisciplinary lessons (pneumologist, nurse, biologist and respiratory therapist) once a week within 1 month after randomization. Study staff will deal with the following topics: asthma physiopathology, recognition of asthma symptoms and exacerbation, educational interventions on therapy and device, nutritional counselling if necessary. Patients will receive a paper diary for symptoms and an expiratory pick flow meter (PFM) to be done twice a day

    Treatment: multidisciplinary lessons

  • CG= Control Group, With no educational interventionNo study treatment, for comparison

    Control group will attend control visits every three months.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Role of "Asthma School" in Disease Management
Plain-language title
Testing group lessons for people with asthma to help manage their diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04442646, who can take part
Record updated
24 April 2026